List of Tables
Table 1. Global Nitinol-based Interventional Cardiology Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Nitinol-based Interventional Cardiology Devices Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Nitinol-based Interventional Cardiology Devices Market Competitive Situation by Manufacturers in 2024
Table 4. Global Nitinol-based Interventional Cardiology Devices Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Nitinol-based Interventional Cardiology Devices Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Nitinol-based Interventional Cardiology Devices Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Nitinol-based Interventional Cardiology Devices Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Nitinol-based Interventional Cardiology Devices Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Nitinol-based Interventional Cardiology Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nitinol-based Interventional Cardiology Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nitinol-based Interventional Cardiology Devices, Product Type & Application
Table 12. Global Key Manufacturers of Nitinol-based Interventional Cardiology Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nitinol-based Interventional Cardiology Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nitinol-based Interventional Cardiology Devices as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nitinol-based Interventional Cardiology Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Nitinol-based Interventional Cardiology Devices Sales by Region (2020-2025) & (K Units)
Table 18. Global Nitinol-based Interventional Cardiology Devices Sales Market Share by Region (2020-2025)
Table 19. Global Nitinol-based Interventional Cardiology Devices Sales by Region (2026-2031) & (K Units)
Table 20. Global Nitinol-based Interventional Cardiology Devices Sales Market Share by Region (2026-2031)
Table 21. Global Nitinol-based Interventional Cardiology Devices Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Nitinol-based Interventional Cardiology Devices Revenue Market Share by Region (2020-2025)
Table 23. Global Nitinol-based Interventional Cardiology Devices Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Nitinol-based Interventional Cardiology Devices Revenue Market Share by Region (2026-2031)
Table 25. North America Nitinol-based Interventional Cardiology Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Nitinol-based Interventional Cardiology Devices Sales by Country (2020-2025) & (K Units)
Table 27. North America Nitinol-based Interventional Cardiology Devices Sales by Country (2026-2031) & (K Units)
Table 28. North America Nitinol-based Interventional Cardiology Devices Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Nitinol-based Interventional Cardiology Devices Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Nitinol-based Interventional Cardiology Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Nitinol-based Interventional Cardiology Devices Sales by Country (2020-2025) & (K Units)
Table 32. Europe Nitinol-based Interventional Cardiology Devices Sales by Country (2026-2031) & (K Units)
Table 33. Europe Nitinol-based Interventional Cardiology Devices Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Nitinol-based Interventional Cardiology Devices Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Nitinol-based Interventional Cardiology Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Nitinol-based Interventional Cardiology Devices Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Nitinol-based Interventional Cardiology Devices Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Nitinol-based Interventional Cardiology Devices Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Nitinol-based Interventional Cardiology Devices Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Nitinol-based Interventional Cardiology Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Nitinol-based Interventional Cardiology Devices Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Nitinol-based Interventional Cardiology Devices Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Nitinol-based Interventional Cardiology Devices Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nitinol-based Interventional Cardiology Devices Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Nitinol-based Interventional Cardiology Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Nitinol-based Interventional Cardiology Devices Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Nitinol-based Interventional Cardiology Devices Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Nitinol-based Interventional Cardiology Devices Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Nitinol-based Interventional Cardiology Devices Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Nitinol-based Interventional Cardiology Devices Sales (K Units) by Type (2020-2025)
Table 51. Global Nitinol-based Interventional Cardiology Devices Sales (K Units) by Type (2026-2031)
Table 52. Global Nitinol-based Interventional Cardiology Devices Sales Market Share by Type (2020-2025)
Table 53. Global Nitinol-based Interventional Cardiology Devices Sales Market Share by Type (2026-2031)
Table 54. Global Nitinol-based Interventional Cardiology Devices Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Nitinol-based Interventional Cardiology Devices Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Nitinol-based Interventional Cardiology Devices Revenue Market Share by Type (2020-2025)
Table 57. Global Nitinol-based Interventional Cardiology Devices Revenue Market Share by Type (2026-2031)
Table 58. Global Nitinol-based Interventional Cardiology Devices Price (US$/Unit) by Type (2020-2025)
Table 59. Global Nitinol-based Interventional Cardiology Devices Price (US$/Unit) by Type (2026-2031)
Table 60. Global Nitinol-based Interventional Cardiology Devices Sales (K Units) by Application (2020-2025)
Table 61. Global Nitinol-based Interventional Cardiology Devices Sales (K Units) by Application (2026-2031)
Table 62. Global Nitinol-based Interventional Cardiology Devices Sales Market Share by Application (2020-2025)
Table 63. Global Nitinol-based Interventional Cardiology Devices Sales Market Share by Application (2026-2031)
Table 64. Global Nitinol-based Interventional Cardiology Devices Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Nitinol-based Interventional Cardiology Devices Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Nitinol-based Interventional Cardiology Devices Revenue Market Share by Application (2020-2025)
Table 67. Global Nitinol-based Interventional Cardiology Devices Revenue Market Share by Application (2026-2031)
Table 68. Global Nitinol-based Interventional Cardiology Devices Price (US$/Unit) by Application (2020-2025)
Table 69. Global Nitinol-based Interventional Cardiology Devices Price (US$/Unit) by Application (2026-2031)
Table 70. Abbott Company Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Nitinol-based Interventional Cardiology Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Abbott Nitinol-based Interventional Cardiology Devices Product
Table 74. Abbott Recent Developments/Updates
Table 75. Edwards Lifesciences Company Information
Table 76. Edwards Lifesciences Description and Business Overview
Table 77. Edwards Lifesciences Nitinol-based Interventional Cardiology Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Edwards Lifesciences Nitinol-based Interventional Cardiology Devices Product
Table 79. Edwards Lifesciences Recent Developments/Updates
Table 80. Medtronic Company Information
Table 81. Medtronic Description and Business Overview
Table 82. Medtronic Nitinol-based Interventional Cardiology Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Medtronic Nitinol-based Interventional Cardiology Devices Product
Table 84. Medtronic Recent Developments/Updates
Table 85. Boston Scientific Company Information
Table 86. Boston Scientific Description and Business Overview
Table 87. Boston Scientific Nitinol-based Interventional Cardiology Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Boston Scientific Nitinol-based Interventional Cardiology Devices Product
Table 89. Boston Scientific Recent Developments/Updates
Table 90. TERUMO Company Information
Table 91. TERUMO Description and Business Overview
Table 92. TERUMO Nitinol-based Interventional Cardiology Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. TERUMO Nitinol-based Interventional Cardiology Devices Product
Table 94. TERUMO Recent Developments/Updates
Table 95. BD Company Information
Table 96. BD Description and Business Overview
Table 97. BD Nitinol-based Interventional Cardiology Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. BD Nitinol-based Interventional Cardiology Devices Product
Table 99. BD Recent Developments/Updates
Table 100. Stryker Company Information
Table 101. Stryker Description and Business Overview
Table 102. Stryker Nitinol-based Interventional Cardiology Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Stryker Nitinol-based Interventional Cardiology Devices Product
Table 104. Stryker Recent Developments/Updates
Table 105. Cook Medical Company Information
Table 106. Cook Medical Description and Business Overview
Table 107. Cook Medical Nitinol-based Interventional Cardiology Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Cook Medical Nitinol-based Interventional Cardiology Devices Product
Table 109. Cook Medical Recent Developments/Updates
Table 110. Cordis Company Information
Table 111. Cordis Description and Business Overview
Table 112. Cordis Nitinol-based Interventional Cardiology Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Cordis Nitinol-based Interventional Cardiology Devices Product
Table 114. Cordis Recent Developments/Updates
Table 115. B. Braun Company Information
Table 116. B. Braun Description and Business Overview
Table 117. B. Braun Nitinol-based Interventional Cardiology Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. B. Braun Nitinol-based Interventional Cardiology Devices Product
Table 119. B. Braun Recent Developments/Updates
Table 120. Biotronik Company Information
Table 121. Biotronik Description and Business Overview
Table 122. Biotronik Nitinol-based Interventional Cardiology Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Biotronik Nitinol-based Interventional Cardiology Devices Product
Table 124. Biotronik Recent Developments/Updates
Table 125. MicroPort Company Information
Table 126. MicroPort Description and Business Overview
Table 127. MicroPort Nitinol-based Interventional Cardiology Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. MicroPort Nitinol-based Interventional Cardiology Devices Product
Table 129. MicroPort Recent Developments/Updates
Table 130. JOTEC Company Information
Table 131. JOTEC Description and Business Overview
Table 132. JOTEC Nitinol-based Interventional Cardiology Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. JOTEC Nitinol-based Interventional Cardiology Devices Product
Table 134. JOTEC Recent Developments/Updates
Table 135. Acandis Company Information
Table 136. Acandis Description and Business Overview
Table 137. Acandis Nitinol-based Interventional Cardiology Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Acandis Nitinol-based Interventional Cardiology Devices Product
Table 139. Acandis Recent Developments/Updates
Table 140. ELLA-CS Company Information
Table 141. ELLA-CS Description and Business Overview
Table 142. ELLA-CS Nitinol-based Interventional Cardiology Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. ELLA-CS Nitinol-based Interventional Cardiology Devices Product
Table 144. ELLA-CS Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Nitinol-based Interventional Cardiology Devices Distributors List
Table 148. Nitinol-based Interventional Cardiology Devices Customers List
Table 149. Nitinol-based Interventional Cardiology Devices Market Trends
Table 150. Nitinol-based Interventional Cardiology Devices Market Drivers
Table 151. Nitinol-based Interventional Cardiology Devices Market Challenges
Table 152. Nitinol-based Interventional Cardiology Devices Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Nitinol-based Interventional Cardiology Devices
Figure 2. Global Nitinol-based Interventional Cardiology Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nitinol-based Interventional Cardiology Devices Market Share by Type: 2024 & 2031
Figure 4. Stents Product Picture
Figure 5. Guidewires Product Picture
Figure 6. Others Product Picture
Figure 7. Global Nitinol-based Interventional Cardiology Devices Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Nitinol-based Interventional Cardiology Devices Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Nitinol-based Interventional Cardiology Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Nitinol-based Interventional Cardiology Devices Market Size (2020-2031) & (US$ Million)
Figure 14. Global Nitinol-based Interventional Cardiology Devices Sales (2020-2031) & (K Units)
Figure 15. Global Nitinol-based Interventional Cardiology Devices Average Price (US$/Unit) & (2020-2031)
Figure 16. Nitinol-based Interventional Cardiology Devices Report Years Considered
Figure 17. Nitinol-based Interventional Cardiology Devices Sales Share by Manufacturers in 2024
Figure 18. Global Nitinol-based Interventional Cardiology Devices Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Nitinol-based Interventional Cardiology Devices Players: Market Share by Revenue in Nitinol-based Interventional Cardiology Devices in 2024
Figure 20. Nitinol-based Interventional Cardiology Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Nitinol-based Interventional Cardiology Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Nitinol-based Interventional Cardiology Devices Sales Market Share by Country (2020-2031)
Figure 23. North America Nitinol-based Interventional Cardiology Devices Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Nitinol-based Interventional Cardiology Devices Sales Market Share by Country (2020-2031)
Figure 27. Europe Nitinol-based Interventional Cardiology Devices Revenue Market Share by Country (2020-2031)
Figure 28. Germany Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Nitinol-based Interventional Cardiology Devices Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Nitinol-based Interventional Cardiology Devices Revenue Market Share by Region (2020-2031)
Figure 35. China Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Nitinol-based Interventional Cardiology Devices Sales Market Share by Country (2020-2031)
Figure 46. Latin America Nitinol-based Interventional Cardiology Devices Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Nitinol-based Interventional Cardiology Devices Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Nitinol-based Interventional Cardiology Devices Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Nitinol-based Interventional Cardiology Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Nitinol-based Interventional Cardiology Devices by Type (2020-2031)
Figure 56. Global Revenue Market Share of Nitinol-based Interventional Cardiology Devices by Type (2020-2031)
Figure 57. Global Nitinol-based Interventional Cardiology Devices Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Nitinol-based Interventional Cardiology Devices by Application (2020-2031)
Figure 59. Global Revenue Market Share of Nitinol-based Interventional Cardiology Devices by Application (2020-2031)
Figure 60. Global Nitinol-based Interventional Cardiology Devices Price (US$/Unit) by Application (2020-2031)
Figure 61. Nitinol-based Interventional Cardiology Devices Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
